Sharon Halperin

575 total citations
8 papers, 196 citations indexed

About

Sharon Halperin is a scholar working on Oncology, Cancer Research and Infectious Diseases. According to data from OpenAlex, Sharon Halperin has authored 8 papers receiving a total of 196 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 4 papers in Cancer Research and 2 papers in Infectious Diseases. Recurrent topics in Sharon Halperin's work include Pancreatic and Hepatic Oncology Research (2 papers), SARS-CoV-2 and COVID-19 Research (2 papers) and Cancer Genomics and Diagnostics (2 papers). Sharon Halperin is often cited by papers focused on Pancreatic and Hepatic Oncology Research (2 papers), SARS-CoV-2 and COVID-19 Research (2 papers) and Cancer Genomics and Diagnostics (2 papers). Sharon Halperin collaborates with scholars based in Israel, United States and Canada. Sharon Halperin's co-authors include Mordechai Gutman, Yaron Vinik, Francisco G. Ortega, Sima Lev, Gordon B. Mills, Raanan Berger, Einat Shmueli, Galia Rahav, Orit Picard and Adi Lahat and has published in prestigious journals such as Science Advances, Annals of Oncology and European Journal of Cancer.

In The Last Decade

Sharon Halperin

8 papers receiving 195 citations

Peers

Sharon Halperin

MB

CR

ONCOL

ID

BE

Gemma Caliendo Italy

Xiaobin Huang China

Grant Ellsworth United States

А. К. Носов Russia

Javad Khanali Iran

C. Codecà Italy

Kelvin Allenson United States

Talal El Zarif United States

Richard de Borja Canada

Chun‐Hao Pan United States

Gemma Caliendo Italy

Sharon Halperin

119 ×1.1

MB

86 ×1.0

CR

84 ×1.4

ONCOL

19 ×0.6

ID

7 ×0.2

BE

Citations per year, relative to Sharon Halperin Sharon Halperin (= 1×) peers Gemma Caliendo

Countries citing papers authored by Sharon Halperin

Since Specialization

Citations

This map shows the geographic impact of Sharon Halperin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sharon Halperin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sharon Halperin more than expected).

Fields of papers citing papers by Sharon Halperin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sharon Halperin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sharon Halperin. The network helps show where Sharon Halperin may publish in the future.

Co-authorship network of co-authors of Sharon Halperin

This figure shows the co-authorship network connecting the top 25 collaborators of Sharon Halperin. A scholar is included among the top collaborators of Sharon Halperin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sharon Halperin. Sharon Halperin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Sahnan, Kapil, Or Goren, Sharon Halperin, et al.. (2024). The Relationship between Treatment Response and Overall Survival in Borderline, Non-Resectable and Resectable Pancreatic Cancer Patients Treated with Neoadjuvant FOLFIRINOX. Journal of Clinical Medicine. 13(17). 5206–5206. 1 indexed citations

2.

Margalit, Ofer, Einat Shacham‐Shmueli, Raanan Berger, et al.. (2022). Seropositivity and neutralising antibodies at six months after BNT162b2 vaccination in patients with solid tumours. European Journal of Cancer. 168. 51–55. 5 indexed citations

3.

Shmueli, Einat, Ofer Margalit, Raanan Berger, et al.. (2021). Efficacy and safety of BNT162b2 vaccination in patients with solid cancer receiving anticancer therapy – a single centre prospective study. European Journal of Cancer. 157. 124–131. 31 indexed citations

4.

Vinik, Yaron, Francisco G. Ortega, Gordon B. Mills, et al.. (2020). Proteomic analysis of circulating extracellular vesicles identifies potential markers of breast cancer progression, recurrence, and response. Science Advances. 6(40). 82 indexed citations

5.

Ben‐Moshe, Noa Bossel, Shlomit Gilad, Gili Perry, et al.. (2018). mRNA-seq whole transcriptome profiling of fresh frozen versus archived fixed tissues. BMC Genomics. 19(1). 419–419. 33 indexed citations

6.

Ofek, Efrat, Damien Urban, Iris Kamer, et al.. (2018). Neoadjuvant pembrolizumab (Pembro) for early stage non-small cell lung cancer (NSCLC): Initial report of a phase I study, MK3475-223. Annals of Oncology. 29. viii486–viii486. 5 indexed citations

7.

Lahat, Adi, Miri Yavzori, Orit Picard, et al.. (2018). Prolonged Recurrent Abdominal Pain is Associated With Ongoing Underlying Mucosal Inflammation in Patients who had an Episode of Acute Complicated Diverticulitis. Journal of Clinical Gastroenterology. 53(5). e178–e185. 22 indexed citations

8.

Golan, Talia, Chani Stossel, Michael Schvimer, et al.. (2017). Pancreatic cancer ascites xenograft-an expeditious model mirroring advanced therapeutic resistant disease. Oncotarget. 8(25). 40778–40790. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact